NF
MRNA icon

NTB Financial’s Moderna MRNA Stock Holding History

NTB Financial’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		$207K Hold
1,448
– – 0.17% 134
2022
Q1 		$249K Sell
1,448
-144
-9% -$24.2K 0.18% 127
2021
Q4 		$404K Buy
+1,592
New +$465K 0.28% 89

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

NTB Financial's MRNA Position: Q2 2022 in Review

NTB Financial held its Moderna (MRNA) position steady in Q2 2022 at 1,448 shares worth $207K. The position accounts for 0.17% of the portfolio, ranked #134.

NTB Financial first reported a position in MRNA in Q4 2021 and has held it in 3 quarters since. The position peaked at $404K in Q4 2021. 981 funds tracked by Wall St. Rank hold MRNA as of Q2 2022.

  • NTB Financial held 1,448 shares of Moderna worth $207K as of Q2 2022.
  • NTB Financial left its Moderna share count unchanged in Q2 2022.
  • Moderna made up 0.17% of NTB Financial's portfolio in Q2 2022, its #134 holding.
  • NTB Financial first reported a position in Moderna in Q4 2021 and has held it in 3 quarters since.
  • NTB Financial's Moderna position peaked at $404K in Q4 2021.
  • 981 funds tracked by Wall St. Rank held Moderna as of Q2 2022.

Based on NTB Financial's 13F filing for Q2 2022, filed 9 Aug 2022.